SMMC-7721 |
Function Assay |
10 μM |
36 h |
DMSO |
down-regulates the protein expression level of phospho-Ser392-p53 |
24286312 |
HuH-7 |
Apoptosis Assay |
20 μM |
48 h |
DMSO |
induces apoptosis |
24286312 |
SMMC-7721 |
Apoptosis Assay |
20 μM |
48 h |
DMSO |
induces apoptosis |
24286312 |
HuH-7 |
Cell Viability Assay |
1.25-20 μM |
24/48/72 h |
DMSO |
inhibits cell proliferation dose and time dependently |
24286312 |
SMMC-7721 |
Cell Viability Assay |
1.25-20 μM |
24/48/72 h |
DMSO |
inhibits cell proliferation dose and time dependently |
24286312 |
RKO |
Function Assay |
20 μM |
24 h |
|
induces HO-1 expression at the level of transcription |
24366007 |
U2OS |
Function Assay |
20 μM |
24 h |
|
induces HO-1 expression at the level of transcription |
24366007 |
RKO |
Function Assay |
20 μM |
24 h |
|
increases the levels of the HO-1 protein as well as the p53 protein |
24366007 |
U2OS |
Function Assay |
20 μM |
24 h |
|
increases the levels of the HO-1 protein as well as the p53 protein |
24366007 |
MOLM |
Function Assay |
10 μM |
24 h |
|
upregulates the SOCS-1 expression |
24473562 |
OCI |
Function Assay |
10 μM |
24 h |
|
upregulates the SOCS-1 expression |
24473562 |
BeWo |
Apoptosis Assay |
30 µM |
24 h |
|
increases apoptosis |
24498154 |
BeWo |
Function Assay |
30 µM |
24 h |
|
increases p53, Mdm2, p21 and Puma at the protein level |
24498154 |
MOML13 |
Function Assay |
10μM |
2/4 h |
|
increases the level of p53 |
24659749 |
AML3 |
Function Assay |
10μM |
2/4 h |
|
increases the level of p53 |
24659749 |
AML2 |
Function Assay |
10μM |
2/4 h |
|
increases the level of p53 |
24659749 |
MOML13 |
Apoptosis Assay |
2/10 μM |
24/48 h |
|
induces apoptosis |
24659749 |
AML2 |
Apoptosis Assay |
2/10 μM |
24/48 h |
|
induces apoptosis |
24659749 |
U2OS |
Function Assay |
20 μM |
24 h |
|
increases the mRNA levels of BCL2A1, BCLXL andBCLW |
24867259 |
Hep3B |
Apoptosis Assay |
|
|
|
induces apoptosis |
24884809 |
Huh-7 |
Apoptosis Assay |
|
|
|
induces apoptosis |
24884809 |
SMMC7721 |
Apoptosis Assay |
|
|
|
induces apoptosis |
24884809 |
HepG2 |
Apoptosis Assay |
|
|
|
induces apoptosis |
24884809 |
Hep3B |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=20.18 ± 1.84 μM |
24884809 |
Huh-7 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=33.96 ± 3.9 μM |
24884809 |
SMMC7721/Ac |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=55.21 ± 5.03 μM |
24884809 |
SMMC7721 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=31.28 ± 4.2 μM |
24884809 |
HepG2/As |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=68.13 ± 9.6 μM |
24884809 |
HepG2 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=35.86 ± 2.9 μM |
24884809 |
MOLM-13 |
Function Assay |
6 μM |
6 h |
DMSO |
enhances the acetylation of histone H2B and heat shock proteins Hsp27 and Hsp90 |
24885082 |
MOLM-13 |
Function Assay |
6 μM |
0-8 h |
DMSO |
increases the levels of p53, MDM2, p21 and acetylated p53 |
24885082 |
115 |
Function Assay |
5 μM |
48 h |
DMSO |
induces p53-dependent senescence |
25067787 |
A498 |
Function Assay |
5 μM |
48 h |
DMSO |
induces p53-dependent senescence |
25067787 |
Caki-2 |
Function Assay |
5 μM |
48 h |
DMSO |
induces p53-dependent senescence |
25067787 |
ACHN |
Function Assay |
5 μM |
48 h |
DMSO |
induces p53-dependent senescence |
25067787 |
115 |
Growth Inhibition Assay |
5 μM |
48 h |
DMSO |
induces cell cycle arrest |
25067787 |
A498 |
Growth Inhibition Assay |
5 μM |
48 h |
DMSO |
induces cell cycle arrest |
25067787 |
Caki-2 |
Growth Inhibition Assay |
5 μM |
48 h |
DMSO |
induces cell cycle arrest |
25067787 |
ACHN |
Growth Inhibition Assay |
5 μM |
48 h |
DMSO |
induces cell cycle arrest |
25067787 |
115 |
Function Assay |
0.5/1/5 μM |
48 h |
DMSO |
leads to increased expression of p53 and some p53 target genes: MDM2, and p21 |
25067787 |
A498 |
Function Assay |
0.5/1/5 μM |
48 h |
DMSO |
leads to increased expression of p53 and some p53 target genes: MDM2, and p21 |
25067787 |
Caki-2 |
Function Assay |
0.5/1/5 μM |
48 h |
DMSO |
leads to increased expression of p53 and some p53 target genes: MDM2, and p21 |
25067787 |
ACHN |
Function Assay |
0.5/1/5 μM |
48 h |
DMSO |
leads to increased expression of p53 and some p53 target genes: MDM2, and p21 |
25067787 |
117 |
Cell Viability Assay |
0.5-10 μM |
0-6 d |
DMSO |
inhibits proliferation in a dose-dependent manner |
25067787 |
115 |
Cell Viability Assay |
0.5-10 μM |
0-6 d |
DMSO |
inhibits proliferation in a dose-dependent manner |
25067787 |
A498 |
Cell Viability Assay |
0.5-10 μM |
0-6 d |
DMSO |
inhibits proliferation in a dose-dependent manner |
25067787 |
Caki-2 |
Cell Viability Assay |
0.5-10 μM |
0-6 d |
DMSO |
inhibits proliferation in a dose-dependent manner |
25067787 |
ACHN |
Cell Viability Assay |
0.5-10 μM |
0-6 d |
DMSO |
inhibits proliferation in a dose-dependent manner |
25067787 |
MCF7 |
Function Assay |
2.5 µM |
48 h |
DMSO |
decreases the homologous DSB repair frequencies |
25085902 |
MCF7 |
Cell Viability Assay |
2.5 µM |
5 d |
DMSO |
sensitizes MCF7 to PARP inhibition |
25085902 |
RAW 264.7 |
Function Assay |
10 μM |
30 min |
|
inhibits LPS-induced NO production |
25172547 |
RAW 264.7 |
Function Assay |
10 μM |
30 min |
|
reduces the LPS-augmented the NF-κB luciferase reporter gene activity |
25172547 |
RAW 264.7 |
Function Assay |
10 μM |
30 min |
|
prevents the p53 reduction in response to LPS |
25172547 |
SUM102PT |
Function Assay |
10 μM |
24 h |
DMSO |
inhibits TGF-β3-induced EPHB2 mRNA and protein expression |
25257729 |
SK-BR-7 |
Function Assay |
10 μM |
24 h |
DMSO |
inhibits TGF-β3-induced EPHB2 mRNA and protein expression |
25257729 |
MCF-10CA1a |
Function Assay |
10 μM |
24 h |
DMSO |
inhibits TGF-β3-induced EPHB2 mRNA and protein expression |
25257729 |
MCF-10CA1a |
Function Assay |
10 μM |
24 h |
DMSO |
decreases the TGF-β3-induced mRNA levels ofMMP2, MMP9, and integrin β 3 |
25257729 |
MCF-10A1 |
Function Assay |
10 μM |
24/48 h |
DMSO |
inhibits migration of normal breast epithelial |
25257729 |
MCF-10CA1a |
Function Assay |
10 μM |
48 h |
DMSO |
inhibits basal invasion and reduced TGF-β3-induced invasion to basal levels |
25257729 |
HCT116 |
Function Assay |
10 µM |
24 h |
|
causes a p53-dependent tetraploid G1-arrest in diploid HCT116 clones D3 and D8 |
25380055 |
A2780 |
Function Assay |
10 μM |
21h |
DMSO |
decreases the FoxM1 levels |
25426548 |
NCI-H23 |
Function Assay |
10 μM |
21h |
DMSO |
decreases the FoxM1 levels |
25426548 |
A2780 |
Function Assay |
10 μM |
21h |
DMSO |
increases p53 protein levels |
25426548 |
NCI-H23 |
Function Assay |
10 μM |
21h |
DMSO |
increases p53 protein levels |
25426548 |
OVCAR10 |
Function Assay |
10 μM |
21h |
DMSO |
increases p53 protein levels |
25426548 |
MCF-7 |
Function Assay |
10 μM |
0-24 h |
|
induces p53 and p21/Cip1 |
25482373 |
SMMC-7721 |
Function Assay |
10 μM |
36 h |
DMSO |
causes the ectopic expression of IFI16 |
25544361 |
SMMC-7721 |
Function Assay |
10 μM |
48 h |
DMSO |
increases the expression level of IFNB1 mRNA |
25544361 |
SMMC-7721 |
Function Assay |
10 μM |
48 h |
DMSO |
induces the chromatin-bound protein IFI16 to partially localize in the cytoplasm |
25544361 |
SMMC-7721 |
Function Assay |
10 μM |
48 h |
DMSO |
causes DNA DSB damage |
25544361 |
DU4475 |
Function Assay |
5/10/20 μM |
24 h |
|
downregulates Toca-1 dose dependently |
25547174 |
MCF-7 |
Function Assay |
10 μM |
|
DMSO |
inhibits cyclin D1 and Dicer |
25702703 |
C2C12 |
Growth Inhibition Assay |
10 μM |
24/48/72 h |
DMSO |
inhibits cells proliferation and differentiation |
25871794 |
L6 |
Growth Inhibition Assay |
10 μM |
24/48/72 h |
DMSO |
inhibits cells proliferation and differentiation |
25871794 |
CRL-5908 |
Growth Inhibition Assay |
|
24 h |
|
IC50=38.71 ± 2.43 μM |
26125230 |
A549-920 |
Growth Inhibition Assay |
|
24 h |
|
IC50=33.85 ± 4.84 μM |
26125230 |
A549-NTC |
Growth Inhibition Assay |
|
24 h |
|
IC50=19.42 ± 1.96 μM |
26125230 |
A549 |
Growth Inhibition Assay |
|
24 h |
|
IC50=17.68 ± 4.52 μM |
26125230 |
C666-1 |
Apoptosis Assay |
10 µM |
48/72 h |
DMSO |
sensitizes C666-1 cells to cisplatin-induced apoptosis |
26252575 |
C666-1 |
Function Assay |
10 µM |
24 h |
DMSO |
activates the p53 pathway, upregulating p53, p21 and Mdm2 |
26252575 |
C666-1 |
Cell Viability Assay |
10 µM |
48 h |
DMSO |
sensitizes C666-1 cells to the cytotoxic effect of cisplatin |
26252575 |
C666-1 |
Growth Inhibition Assay |
|
|
|
IC50=19.95±8.93 μM |
26252575 |
NP460 |
Growth Inhibition Assay |
|
|
|
IC50=22.85±1.18 μM |
26252575 |
NP69 |
Growth Inhibition Assay |
|
|
|
IC50=31.69±2.54 μM |
26252575 |
MCF7 |
Growth Inhibition Assay |
5 μM |
48 h |
|
blocks 27-OHC-induced cell proliferation comparable to that of basal levels |
26350565 |
HuH-7 |
Function Assay |
10 μM |
36 h |
DMSO |
down-regulates the protein expression level of phospho-Ser392-p53 |
24286312 |
AT2 |
Function Assay |
5/10 μM |
|
|
leads to a substantial accumulation of the p53 protein as well as the expression of its direct targets p21, MDM2 and the pro-apoptotic BAX and PUMA proteins |
24240203 |
REH |
Function Assay |
5/10 μM |
|
|
leads to a substantial accumulation of the p53 protein as well as the expression of its direct targets p21, MDM2 and the pro-apoptotic BAX and PUMA proteins |
24240203 |
UoCB6 |
Function Assay |
5/10 μM |
|
|
leads to a substantial accumulation of the p53 protein as well as the expression of its direct targets p21, MDM2 and the pro-apoptotic BAX and PUMA proteins |
24240203 |
AT2 |
Cell Viability Assay |
0-25 μM |
|
|
inhibits cell viability dose dependently |
24240203 |
REH |
Cell Viability Assay |
0-25 μM |
|
|
inhibits cell viability dose dependently |
24240203 |
UoCB6 |
Cell Viability Assay |
0-25 μM |
|
|
inhibits cell viability dose dependently |
24240203 |
A2780 |
Function Assay |
5/10/20 μM |
24 h |
|
upregulates p53, MDM2, p21 and DR5 protein levels dose dependently |
24136147 |
H460 |
Function Assay |
5/10/20 μM |
24 h |
|
upregulates p53, MDM2, p21 and DR5 protein levels dose dependently |
24136147 |
Lovo |
Function Assay |
5/10/20 μM |
24 h |
|
upregulates p53, MDM2, p21 and DR5 protein levels dose dependently |
24136147 |
A2780 |
Apoptosis Assay |
5/10/20 μM |
24 h |
|
enhances apoptosis induction by D269H/E195R over rhTRAIL |
24136147 |
H460 |
Apoptosis Assay |
5/10/20 μM |
24 h |
|
enhances apoptosis induction by D269H/E195R over rhTRAIL |
24136147 |
Lovo |
Apoptosis Assay |
5/10/20 μM |
24 h |
|
enhances apoptosis induction by D269H/E195R over rhTRAIL |
24136147 |
U87MG |
Function assay |
|
10 mins |
|
Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay, IC50 = 0.1045 μM. |
27050782 |
U87MG |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human U87MG cells expressing wild type p53 after 48 hrs by MTS assay, IC50 = 6.5 μM. |
27050782 |
U343MG |
Antiproliferative assay |
|
48 hrs |
|
Antiproliferative activity against human U343MG cells expressing wild type p53 after 48 hrs by MTS assay, IC50 = 12.6 μM. |
27050782 |
SW620 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human SW620 cells after 72 hrs by SRB assay, IC50 = 0.38 μM. |
ChEMBL |
A549 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human A549 cells after 72 hrs by SRB assay, IC50 = 0.41 μM. |
ChEMBL |
SJSA1 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human SJSA1 cells after 72 hrs by SRB assay, IC50 = 1.81 μM. |
ChEMBL |
HCT116 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay, IC50 = 4.63 μM. |
ChEMBL |
PC3 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human PC3 cells after 72 hrs by SRB assay, IC50 = 6.37 μM. |
ChEMBL |